Literature DB >> 26286207

Regulation of Gene Expression by Sodium Valproate in Epithelial-to-Mesenchymal Transition.

Shuhei Noguchi1, Masamitsu Eitoku1, Shigeharu Moriya2, Shinji Kondo3, Hidenori Kiyosawa1, Takashi Watanabe4,5, Narufumi Suganuma6.   

Abstract

PURPOSE: Epithelial-to-mesenchymal transition (EMT) is an important mechanism in cancer metastasis and pulmonary fibrosis. Previous studies demonstrated effect of histone H3 and H4 acetylation in cancer and pulmonary fibrosis, so we hypothesized that histone modification might play a crucial role in gene regulation during EMT. In this study, we investigated the mechanism behind EMT by analyzing comprehensive gene expression and the effect of sodium valproate (VPA), a class I histone deacetylase inhibitory drug, on histone modification.
METHODS: EMT was induced in human alveolar epithelial cells (A549) using 5 ng/mL of transforming growth factor (TGF)-β1. Various concentrations of VPA were then administered, and Western blotting was used to analyze histone acetylation or methylation. Comprehensive gene expression analysis was carried out by RNA sequencing, and chromatin immunoprecipitation was performed with an anti-acetyl histone H3 lysine 27 antibody.
RESULTS: TGF-β1 stimulation led to a decrease in histone acetylation, especially that of histone H3K27, and H3K27ac localization was decreased at particular gene loci. This decrease was recovered by VPA treatment, which also up-regulated the mRNA expression of genes down-regulated by TGF-β1, and correlated with the localization of H3K27ac. However, genes up-regulated by TGF-β1 stimulation were not suppressed by VPA, with the exception of COL1A1.
CONCLUSIONS: Histone acetylation was down-regulated by TGF-β1 stimulation in A549 cells. VPA partially inhibited EMT and the decrease of histone acetylation, which plays an important role in the progression of EMT.

Entities:  

Keywords:  Epithelial-to-mesenchymal transition; Histone modification; Non-small cell lung cancer; Pulmonary fibrosis; RNA-Seq; Sodium valproate

Mesh:

Substances:

Year:  2015        PMID: 26286207     DOI: 10.1007/s00408-015-9776-9

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  45 in total

1.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.

Authors:  M Göttlicher; S Minucci; P Zhu; O H Krämer; A Schimpf; S Giavara; J P Sleeman; F Lo Coco; C Nervi; P G Pelicci; T Heinzel
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

2.  Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice.

Authors:  Shizuya Saika; Kazuo Ikeda; Osamu Yamanaka; Kathleen C Flanders; Yoshitaka Ohnishi; Yuji Nakajima; Yasuteru Muragaki; Akira Ooshima
Journal:  Am J Physiol Cell Physiol       Date:  2005-08-24       Impact factor: 4.249

3.  Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line.

Authors:  Jin Kyung Rho; Yun Jung Choi; Jin Kyung Lee; Baek-Yeol Ryoo; Im Il Na; Sung Hyun Yang; Cheol Hyeon Kim; Jae Cheol Lee
Journal:  Lung Cancer       Date:  2008-07-02       Impact factor: 5.705

Review 4.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

5.  Inhibition of epithelial-to-mesenchymal transition and pulmonary fibrosis by methacycline.

Authors:  Ying Xi; Kevin Tan; Alexis N Brumwell; Steven C Chen; Yong-Hyun Kim; Thomas J Kim; Ying Wei; Harold A Chapman
Journal:  Am J Respir Cell Mol Biol       Date:  2014-01       Impact factor: 6.914

6.  TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).

Authors:  Hidenori Kasai; Jeremy T Allen; Roger M Mason; Takashi Kamimura; Zhi Zhang
Journal:  Respir Res       Date:  2005-06-09

7.  Laminin gamma2 fragments are increased in the circulation of patients with early phase acute lung injury.

Authors:  Masahiko Katayama; Akitoshi Ishizaka; Michiie Sakamoto; Seitaro Fujishima; Kiyotoshi Sekiguchi; Koichiro Asano; Tomoko Betsuyaku; Toru Kotani; Lorraine B Ware; Michael A Matthay; Satoru Hashimoto
Journal:  Intensive Care Med       Date:  2009-11-26       Impact factor: 17.440

8.  Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts.

Authors:  S K Huang; A M Scruggs; J Donaghy; J C Horowitz; Z Zaslona; S Przybranowski; E S White; M Peters-Golden
Journal:  Cell Death Dis       Date:  2013-05-02       Impact factor: 8.469

9.  Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts.

Authors:  Xiangyu Zhang; Hui Liu; Thomas Hock; Victor J Thannickal; Yan Y Sanders
Journal:  Int J Mol Sci       Date:  2013-09-27       Impact factor: 5.923

10.  Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells.

Authors:  J Liu; G Hu; D Chen; A-Y Gong; G S Soori; T J Dobleman; X-M Chen
Journal:  Oncogenesis       Date:  2013-09-23       Impact factor: 7.485

View more
  9 in total

1.  HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells.

Authors:  Clotilde Hoyos; Alexis Fontaine; Jean-Rock Jacques; Vincent Heinen; Renaud Louis; Bernard Duysinx; Arnaud Scherpereel; Eric Wasielewski; Majeed Jamakhani; Malik Hamaidia; Luc Willems
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

Review 2.  Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.

Authors:  Martina Korfei; Poornima Mahavadi; Andreas Guenther
Journal:  Cells       Date:  2022-05-12       Impact factor: 7.666

3.  Residual Ammonium Persulfate in Nanoparticles Has Cytotoxic Effects on Cells through Epithelial-Mesenchymal Transition.

Authors:  Chen Song; Leyu Wang; Genlan Ye; Xiaoping Song; Yutong He; Xiaozhong Qiu
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

Review 4.  Reactive Oxygen Species Drive Epigenetic Changes in Radiation-Induced Fibrosis.

Authors:  Shashank Shrishrimal; Elizabeth A Kosmacek; Rebecca E Oberley-Deegan
Journal:  Oxid Med Cell Longev       Date:  2019-02-06       Impact factor: 6.543

5.  The effect of sodium butyrate and cisplatin on expression of EMT markers.

Authors:  Alena Mrkvicova; Marcela Chmelarova; Eva Peterova; Radim Havelek; Ivana Baranova; Petra Kazimirova; Emil Rudolf; Martina Rezacova
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

Review 6.  Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells.

Authors:  Anna Wawruszak; Joanna Kalafut; Estera Okon; Jakub Czapinski; Marta Halasa; Alicja Przybyszewska; Paulina Miziak; Karolina Okla; Adolfo Rivero-Muller; Andrzej Stepulak
Journal:  Cancers (Basel)       Date:  2019-01-27       Impact factor: 6.639

Review 7.  HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis.

Authors:  Xing Lyu; Min Hu; Jieting Peng; Xiangyu Zhang; Yan Y Sanders
Journal:  Ther Adv Chronic Dis       Date:  2019-07-18       Impact factor: 4.970

Review 8.  More than a Genetic Code: Epigenetics of Lung Fibrosis.

Authors:  Krystian Bartczak; Adam J Białas; Mateusz J Kotecki; Paweł Górski; Wojciech J Piotrowski
Journal:  Mol Diagn Ther       Date:  2020-12       Impact factor: 4.074

9.  Pretreatment with valproic acid alleviates pulmonary fibrosis through epithelial-mesenchymal transition inhibition in vitro and in vivo.

Authors:  Lin Chen; Azeem Alam; Aurelie Pac-Soo; Qian Chen; You Shang; Hailin Zhao; Shanglong Yao; Daqing Ma
Journal:  Lab Invest       Date:  2021-06-24       Impact factor: 5.662

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.